AHA Scientific Sessions 2026 Abstract
Inflammation protein may help refine heart disease risk estimates
The inflammation marker interleukin-6 separated event rates between people reassigned to higher and lower risk groups by 1.15 per 1,000 person-years, versus 0.54 for…The inflammation marker interleukin-6 separated event rates between people reassigned to higher and lower risk groups by 1.15 per 1,000 person-years, versus 0.54 for C-reactive protein.
Cohort · 32,920 peopleBiomarkers
Who was studied32,920 adults without cardiovascular disease, 10 years
What changedInterleukin-6 separated cardiovascular event rates after risk reassignment by 1.15 versus 0.54 per 1,000 person-years for C-reactive protein
The catchThe analysis measured risk reclassification, not cardiovascular benefits from IL-6-guided treatment
